Anaplastic Large Cell Lymphoma, ALK-negative

Showing 1 - 8 of 8

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

T-cell Lymphoma, NK-Cell Lymphoma, T-cell Prolymphocytic Leukemia Trial in United States (Optional Blood Sample, Optional Nail

Recruiting
  • T-cell Lymphoma
  • +30 more
  • Optional Blood Sample
  • Optional Nail Sample
  • Duarte, California
  • +25 more
Jul 28, 2023

Adenoid Cystic Skin Carcinoma, Adnexal Carcinoma, Anaplastic Large Cell Lymphoma, ALK-Negative Trial in United States

Recruiting
  • Adenoid Cystic Skin Carcinoma
  • +38 more
  • Biopsy
  • +6 more
  • Los Angeles, California
  • +35 more
Jan 31, 2023

Anaplastic Large Cell Lymphoma, ALK-Negative, Anaplastic Large Cell Lymphoma, ALK-Positive, Hepatosplenic T-Cell Lymphoma Trial

Completed
  • Anaplastic Large Cell Lymphoma, ALK-Negative
  • +9 more
  • Autologous Hematopoietic Stem Cell Transplantation
  • +8 more
  • Duarte, California
  • +7 more
Nov 4, 2022

Peripheral T Cell Lymphoma, PTCL, Extranodal NK/T-cell Lymphoma Trial in Worldwide (Tislelizumab)

Completed
  • Peripheral T Cell Lymphoma
  • +18 more
  • Vancouver, British Columbia, Canada
  • +29 more
Apr 29, 2022

T Lymphoblastic Leukemia/Lymphoma, Extramedullary NK-T-cell Lymphoma, Nasal Type, Peripheral T-cell Lymphoma, Nonspecific Trial

Recruiting
  • T Lymphoblastic Leukemia/Lymphoma
  • +6 more
  • T cell injection targeting CD7 chimeric antigen receptor
  • Zhengzhou, Henan, China
    First Affiliated Hospital of Zhengzhou University
Jan 4, 2021

Anaplastic Large Cell Lymphoma, ALK-Negative, Recurrent Anaplastic Large Cell Lymphoma, Recurrent Mantle Cell Lymphoma Trial in

Completed
  • Anaplastic Large Cell Lymphoma, ALK-Negative
  • +5 more
  • Autologous Hematopoietic Stem Cell Transplantation
  • +6 more
  • Westwood, Kansas
  • +2 more
Nov 7, 2019

Risk Stratification of Nodal PTCL

Completed
  • Peripheral T-Cell Lymphoma, Not Otherwise Specified
  • +2 more
    • Jeonju, Korea, Republic of
      Chonbuk Nationla University Hospital
    Aug 5, 2019

    Peripheral T Cell Lymphoma Unspecified, Anaplastic Large Cell Lymphoma, ALK-negative, Angioimmunoblastic T Cell Lymphoma Trial

    Completed
    • Peripheral T Cell Lymphoma Unspecified
    • +3 more
    • RAD001 (Everolimus)
    • Goyang-si, Kyoungki-do, Korea, Republic of
    • +4 more
    Mar 1, 2015